JUPITER NEUROSCIENCES, INC. S-1 Filing

From the Filing

0001493152-25-025204.txt : 20251126 0001493152-25-025204.hdr.sgml : 20251126 20251126172802 ACCESSION NUMBER: 0001493152-25-025204 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 77 FILED AS OF DATE: 20251126 DATE AS OF CHANGE: 20251126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JUPITER NEUROSCIENCES, INC. CENTRAL INDEX KEY: 0001679628 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 474828381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-291832 FILM NUMBER: 251531585 BUSINESS ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 BUSINESS PHONE: (561) 406-6154 MAIL ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 FORMER COMPANY: FORMER CONFORMED NAME: Jupiter Orphan Therapeutics, Inc. DATE OF NAME CHANGE: 20160713 S-1 1 forms-1.htm S-1 false 0001679628 0001679628 2025-01-01 2025-09-30 0001679628 dei:BusinessContactMember 2025-01-01 2025-09-30 0001679628 2024-12-31 0001679628 2023-12-31 0001679628 us-gaap:RelatedPartyMember 2024-12-31 0001679628 us-gaap:RelatedPartyMember 2023-12-31 0001679628 us-gaap:SeriesAPreferredStockMember 2024-12-31 0001679628 us-gaap:SeriesAPreferredStockMember 2023-12-31 0001679628 2025-09-30 0001679628 us-gaap:RelatedPartyMember 2025-09-30 0001679628 us-gaap:SeriesAPreferredStockMember 2025-09-30 0001679628 2024-01-01 2024-12-31 0001679628 2023-01-01 2023-12-31 0001679628 2025-07-01 2025-09-30 0001679628 2024-07-01 2024-09-30 0001679628 2024-01-01 2024-09-30 0001679628 us-gaap:CommonStockMember 2023-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001679628 us-gaap:RetainedEarningsMember 2023-12-31 0001679628 us-gaap:CommonStockMember 2022-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001679628 us-gaap:RetainedEarningsMember 2022-12-31 0001679628 2022-12-31 0001679628 us-gaap:CommonStockMember 2025-06-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2025-06-30 0001679628 us-gaap:RetainedEarningsMember 2025-06-30 0001679628 2025-06-30 0001679628 us-gaap:CommonStockMember 2024-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001679628 us-gaap:RetainedEarningsMember 2024-12-31 0001679628 us-gaap:CommonStockMember 2024-06-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-06-30 0001679628 us-gaap:RetainedEarningsMember 2024-06-30 0001679628 2024-06-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2023-12-31 0001679628 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0001679628 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0001679628 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001679628 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001679628 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2025-07-01 2025-09-30 0001679628 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001679628 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001679628 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001679628 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-07-01 2024-09-30 0001679628 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001679628 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0001679628 JUNS:ReceivablesForSaleOfStockMember 2024-01-01 2024-09-30 0001679